The roles of prostate‐specific antigen (PSA) density, prostate volume, and their zone‐adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Andrology

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/andr.12322PMID 28409907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transition Zone Prostate-specific Antigen Density Could Better Guide the Rebiopsy Strategy in Men With Prostate Inflammation at Initial Biopsy.

  2015cited by this paper
• Transperineal Ultrasound-Guided 12-Core Prostate Biopsy: An Extended Approach to Diagnose Transition Zone Prostate Tumors

  2014cited by this paper
• Guidelines on Prostate Cancer

  2013cited by this paper
• Prediction of the Risk of Harboring Prostate Cancer by a Prebiopsy Nomogram Based on Extended Biopsy Protocol

  2013cited by this paper
• Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region.

  2013cited by this paper
• Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men.

  2013cited by this paper
• Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme

  2011cited by this paper
• Predicting the probability of significant prostate cancer in Japanese men with serum prostate‐specific antigen less than 10 ng/mL: Development of a novel pre‐biopsy nomogram

  2010cited by this paper
• Validación prospectiva de un nomograma predictivo de la presencia de cáncer de próstata en pacientes que se someten a biopsia transrectal ecodirigida de 10 cilindros

  2010cited by this paper
• [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].

  2010cited by this paper
• Should transition zone biopsies be added to 12‐core systematic biopsies of the prostate?

  2009cited by this paper
• PSA screening--a review of recent studies.

  2009cited by this paper
• History of malignancy is a predictor of prostate cancer detection: Incorporation into a pre‐biopsy nomogram

  2008cited by this paper
• The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes.

  2008cited by this paper
• Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones

  2006cited by this paper
• Development and internal validation of preoperative transition zone prostate cancer nomogram.

  2006cited by this paper
• Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.

  2005cited by this paper
• [Comparison of value of free-to total prostate specific antigen, prostate specific antigen density and prostate specific antigen density of transition zone for diagnosis of prostate cancer in patients with a PSA level of 4.1-10 ng/ml].

  2005cited by this paper
• Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound‐guided prostate biopsies

  2005cited by this paper
• Importance of Transition Zone Prostate Biopsies in Patients with Gray-Zone PSA Levels Undergoing the Ultrasound-Guided Systematic Ten-Biopsy Regimen for the First Time

  2005cited by this paper
• Comparison of Prostate‐Specific Antigen Adjusted for Transition Zone Volume Versus Prostate‐Specific Antigen Density in Predicting Prostate Cancer by Transrectal Ultrasonography

  2004cited by this paper
• Valor de la densidad del antígeno prostático específico y de la densidad del antígeno prostático específico de la zona transicional en el diagnóstico del cáncer de próstata

  2003cited by this paper
• Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour

  2003cited by this paper
• [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].

  2003cited by this paper
• Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?

  2003cited by this paper
• Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.

  1999cited by this paper
• Prostate specific antigen density of the transition zone for early detection of prostate cancer.

  1998cited by this paper
• Value of Systematic Transition Zone Biopsy in the Detection of Prostate Cancer

  1997influential reference
• Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.

  1995influential reference
• Interexaminer variability of digital rectal examination in detecting prostate cancer.

  1995cited by this paper
• Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate.

  1994influential reference
• Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread

  1988influential reference
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper

• Dual-Functionalized Glass Micropipette Sensor for Simultaneous High Sensitivity Detection of Cancer Biomarkers.

  2025cites this paper
• Combined predictive model for prostate cancer screening: Development and validation study

  2025cites this paper
• Increased GPR35 expression is correlated with poor prognosis in prostate cancer

  2025cites this paper
• Prediction of clinically significant prostate cancer using extra-transitional zone prostate-specific antigen among Taiwanese men.

  2025cites this paper
• Apparent differences in prostate zones: susceptibility to prostate cancer, benign prostatic hyperplasia and prostatitis

  2024cites this paper
• Clinical value of a radiomics model based on machine learning for the prediction of prostate cancer

  2024influential citation
• Digital droplet immunoassay based on a microfluidic chip with magnetic beads for the detection of prostate-specific antigen.

  2023cites this paper
• Significance of the Prostate Central Gland and Total Gland Volume Ratio in the Diagnosis of Prostate Cancer Patients in the PSA Gray Zone

  2021cites this paper
• Significance of the prostate central gland and total gland volume ratio in the diagnosis of prostate cancer patients in the prostate specific antigen grey zone

  2021cites this paper
• MRI-Based Nomogram of Prostate Maximum Sectional Area and Its Zone Area for Prediction of Prostate Cancer

  2021cites this paper
• Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making

  2021cites this paper
• Biomarkers in the setting of benign prostatic HyperplasiaInduced lower urinary tract symptoms: What an interventional radiologist needs toKnow.

  2020cites this paper
• The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer

  2019cites this paper
• Comparison of PSA-density of the transition zone and whole gland for risk stratification of men with suspected prostate cancer: A retrospective MRI-cohort study.

  2019cites this paper
• A novel fluorescent probe for the early detection of prostate cancer based on endogenous zinc sensing

  2019cites this paper
• Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy

  2019cites this paper
• Increased level of miRNA 30b-3p in patients with prostatic hyperplasia and testosterone with high-level of prostate-specific antigen

  2018cites this paper
• Early diagnostic role of PSA combined miR-155 detection in prostate cancer.

  2018cites this paper
• Prediction models for prostate cancer outcomes: what is the state of the art in 2017?

  2017cites this paper